Global Emerging Pathogens Treatment Consortium
The Global Emerging Pathogens Treatment Consortium (GET Africa) is a non-profit Pan-African consortium advancing biosecurity and pandemic preparedness across West Africa through a molecular biobank, policy advisory, researcher training, and an annual One Health conference.
- Company typePrivate
- Founded2014
- HeadquartersIbadan, Nigeria
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Global Emerging Pathogens Treatment Consortium does
The Global Emerging Pathogens Treatment Consortium (GET), branded as GET Africa, is a non-profit Pan-African multidisciplinary consortium founded in 2014 in direct response to the 2014-16 West African Ebola Virus Disease outbreak. Operating from its Lagos, Nigeria headquarters (with a contact office in Ibadan), GET assembles experts across infectious diseases, hematology, bioinformatics, biobanking, ethics, social science, and policy to address pandemic preparedness and biosecurity gaps across the African continent. Its service portfolio spans physical infrastructure (the Lagos State Public Health Molecular Laboratory with Biobank Facility, commissioned 2018), human capital development (GET Biosecurity Fellowship Program, GET One Health School Club), policy and advisory outputs (technical papers, quarterly newsletter across 15 volumes, 12-part policy brief series, the WAHO-developed ECOWAS integrated biosecurity policy), and convening platforms (annual GET Conference on One Health and Biosecurity, GET Summit, GET Webinar Series, and eight active working groups covering Ethics/Community Engagement, One Health, CASE, Modelling & Intelligence, Grants Publications & Proposals, Research & Clinical, Plasmapheresis, and Biobanking). The Lagos State Biobank's capacity was demonstrated when it tested approximately 30% of Nigeria's COVID-19 cases at the pandemic peak while linked into the Nigerian Centre for Disease Control's laboratory network. GET monetizes primarily via grant funding from organizations including the Bill & Melinda Gates Foundation and Global Partnership Program, Canada, supplemented by transaction-based revenue from conference registrations ($50-250 per delegate) and event sponsorships ($2,000-$20,000). Target users include African governments and health ministries (notably Lagos State Ministry of Health, NCDC, WAHO), mid-career researchers and biosecurity fellows, secondary-school students via the One Health School Club, and policy/industry stakeholders reached through conferences and publications. Cross-border operations have spanned Guinea, Liberia, Sierra Leone, and Senegal, in addition to Nigeria.
Global Emerging Pathogens Treatment Consortium firmographics
Firmographics- Name
- Global Emerging Pathogens Treatment Consortium
- Legal name
- Global Emerging Pathogens Treatment Consortium
- Website
- https://getafrica.org
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Global Emerging Pathogens Treatment Consortium (GET Africa) is a non-profit Pan-African consortium advancing biosecurity and pandemic preparedness across West Africa through a molecular biobank, policy advisory, researcher training, and an annual One Health conference.
- Ownership category
- akta.pro rank
Global Emerging Pathogens Treatment Consortium industry classification
Industry- Product category
- Public Health and Biosecurity Research Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Emerging Pathogen & Outbreak Response Testing Networks (HLAJAIAE)
- akta.pro secondary industries
- One Health & Zoonotic Disease Partnerships (Human–Animal–Environment) (HLAJAOAJ), Global Health Security & Pandemic Preparedness Partnerships (HLAJAOAH), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)
Keywords
Where Global Emerging Pathogens Treatment Consortium is headquartered
LocationHeadquarters
- HQ city
- Ibadan
- HQ country
- Nigeria
- HQ region
- Africa
Offices2 records
Markets served
Global Emerging Pathogens Treatment Consortium business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Conference Fees and Sponsorships: Revenue generated from conference registration fees (students $50, African delegates $150, non-African delegates $250) and sponsorship packages (Platinum $20,000, Gold $10,000, Silver $5,000, Bronze $2,000).
- Grant Funding: Funding from international organizations and foundations including Bill & Melinda Gates Foundation and Global Partnership Program, Canada for pandemic preparedness and biosecurity initiatives.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | One time | Student Registration |
| Subscription | One time | African Delegate In-Person |
| Subscription | One time | Non-African Delegate In-Person |
| Subscription | One time | Virtual Participation |
| Other | One time | Platinum Sponsorship |
| Other | One time | Gold Sponsorship |
| Other | One time | Silver Sponsorship |
| Other | One time | Bronze Sponsorship |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Global Emerging Pathogens Treatment Consortium product offering
Product offeringCore offering
Global Emerging Pathogens Treatment Consortium (GET) is a Pan-African non-profit consortium that delivers research, policy advocacy, training, and operational biosecurity infrastructure for pandemic preparedness across Africa. It operates the Lagos State Public Health Molecular Laboratory and Biobank Facility, runs the annual African Conference on One Health and Biosecurity, manages educational programs (Biosecurity Fellowship, One Health School Club), and conducts working groups spanning ethics, plasmapheresis, biobanking, and disease modeling.
Product overview
Global Emerging Pathogens Treatment Consortium (GET) operates as a Pan-African non-profit think tank focused on African biosecurity and pandemic preparedness. The organization offers a portfolio of products and programs including: research and publications (GET Book, GET Technical Paper series, Policy Brief Series, Newsletters); infrastructure (Lagos State Public Health Molecular Laboratory with Biobank Facility, GET Institute of Biosecurity); educational programs (GET One Health School Club, GET Biosecurity Fellowship Program); events (annual GET Conference on One Health and Biosecurity, GET Summit, GET Webinar Series); and specialized working groups (ECEPAS, CASE, One Health, GPP, Modelling & Intelligence, Research & Clinical, Plasmapheresis & Fractionation, Biobanking). The consortium functions as a multi-faceted organization providing advocacy, expertise, and operational support to African countries for outbreak response and public health emergencies.
Differentiator
Problem solved
Functional benefit
Products and services
- Lagos State Public Health Molecular Laboratory with Biobank Facility A Public Health Molecular Laboratory with Biobank Facility established in Lagos State to diagnose diseases of public health importance, respond to biosecurity threats, bank biological samples, design diagnostic tools, and conduct medical research. Equipped with Real-time PCR, ELISA for serology and vaccine monitoring, proteomics, and sequencing capabilities.
- GET Institute of Biosecurity A think tank providing strategic direction, policy and technical solutions, and national-level coordination to address biological threats in Africa and support pandemic preparedness.
- GET One Health School Club (GHSC) A student-focused club initiative to introduce the One Health concept to senior secondary students, covering topics such as antimicrobial resistance, biosecurity, emerging infectious diseases, waste management, and environmental sustainability.
- GET Biosecurity Fellowship Program (GBFP) A competitive five-month research fellowship in Biosecurity and One Health for mid-career African academics, researchers, or policymakers focusing on One Health approach, BWC implementation, and genomic intelligence. Includes stipend, health insurance, and accommodation.
- GET Webinar Series Virtual seminar series covering COVID-19 topics, pandemic response, vaccine trials, frontline health workers, and global biosecurity threats.
- GET Conference Annual African Conference on One Health and Biosecurity bringing together policymakers, researchers, scientists, and industry leaders with over 400 expected participants. Registration fees vary by delegate category (students $50, African $150, non-African $250).
- West African Health Organization (WAHO) Project Collaboration with WAHO to develop framework studies on biosecurity in West Africa, including data governance framework, biosecurity/biobanking review, and ECOWAS integrated biosecurity policy.
- GET Book A book titled 'Socio-Cultural Dimensions Of Emerging Infectious Diseases In Africa: An Indigenous Response To Deadly Epidemics' edited by Tangwa, G.B., Abayomi, A., Ujewe, S.J., and Munung, N.S., providing an interdisciplinary approach to global health problems.
- GET Technical Paper Series Technical publications covering governance and strategies for dual-use research, biodefense strategy, and vaccine distribution strategy in West Africa.
- GET Policy Brief Series Policy brief series (I-XII) addressing topics such as Omicron control, bioeconomy, and effective measures for controlling the spread of infectious diseases.
- GET Newsletter Quarterly newsletter of the Consortium covering news, research updates, and consortium activities across 15 volumes.
Quantifiable outcome
- Testing over 30% of Nigeria's COVID-19 cases at peak
- +3 more outcomes
Companies that use Global Emerging Pathogens Treatment Consortium
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Global Emerging Pathogens Treatment Consortium technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Global Emerging Pathogens Treatment Consortium partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and major.
- Global Partnership Program, Canada (GPP Canada)coreFunded the establishment of a Public Health Molecular Laboratory with Biobank Facility in Lagos State, Nigeria. Sponsored design and construction phases through contractor African Filter Maintenance Services, South Africa. Provided initial equipment and reagents.
- West African Health Organization (WAHO)coreCollaborated to develop detailed framework studies on biosecurity in West Africa, including data governance framework, narrative report on biosecurity frameworks, and ECOWAS integrated biosecurity policy.
- West African Task Force for Research into Emerging Infectious Diseases (WATER)majorCo-hosted first African conferences on Emerging Infectious Diseases in Dakar, Senegal. Conference outcomes known as the Dakar Declaration, addressing physical and human capacity deficiencies.
- Lagos State GovernmentcoreSponsored Environmental Impact Assessment, provided additional equipment and reagents, conducted training for laboratory personnel, and approved the Governing Council for the laboratory facility.
- International Federation of Biosafety Associations (IFBA)majorProvided international certification examination for Lagos State Biobank personnel, who demonstrated competency and proficiency to achieve international certification.
- VERTICmajorConducted legislative review of Sierra Leone laws to assess gaps requiring strengthening to ensure compliance with international treaties on biosecurity and public health preparedness.
- Nigeria Centre for Disease Control (NCDC)coreApproved and linked Lagos State Biobank to the Network of Molecular Laboratories in Nigeria for COVID-19 diagnosis.
- Ebola Survivors Association of Liberia (ESAL)majorCo-hosted survivor workshop in Monrovia focused on stigma and hardship faced by Ebola survivors, resulting in increased registered survivors from 500 to 800.
- Sierra Leone Association of Ebola Survivors (SLAES)majorCo-hosted survivor workshop in Freetown to address challenges faced by Ebola survivors.
- United States, Europe and Asia CollaboratorsmajorInternational partners collaborated with GET Consortium during Ebola response, bringing expertise in various disciplines.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Global Emerging Pathogens Treatment Consortium competitors and assessment
Company assessmentDirect peers
- West African Health Organization (WAHO): WAHO is the ECOWAS health agency with which GET has a deep partnership, collaborating on the ECOWAS integrated biosecurity policy. WAHO operates as a regional coordinating body for health security across 15 West African countries, overlapping directly with GET's regional policy and biosecurity scope.
- Institut Pasteur de Dakar: Institut Pasteur de Dakar is a leading West African biomedical research organisation focused on infectious diseases, vaccine production, and diagnostic capacity. It parallels GET's biobanking and molecular laboratory capabilities and its mandate for African-led outbreak response.
- FIND (Foundation for Innovative New Diagnostics): FIND is a global diagnostics-focused organisation that works on diagnostic test access and laboratory capacity in low- and middle-income countries, including Africa. It is closely comparable to GET's laboratory and diagnostic capacity-building mission.
- Africa One Health University Network (AFROHUN): AFROHUN is a network of universities across Africa implementing One Health workforce development programs. It directly overlaps with GET's One Health School Club and fellowship programs focused on building interdisciplinary biosecurity talent.
- African Society for Laboratory Medicine (ASLM): ASLM is a pan-African professional society focused on strengthening laboratory medicine and networks across the continent. It directly overlaps with GET's interest in laboratory workforce capacity, quality standards, and biobanking infrastructure in Africa.
- Nigeria Centre for Disease Control (NCDC): NCDC is Nigeria's national public health institute, and the Lagos State Biobank is linked to NCDC's network of molecular laboratories for COVID-19 diagnosis. Both organisations operate in the infectious disease surveillance and laboratory response space in Nigeria.
Broad incumbents
- Coalition for Epidemic Preparedness Innovations (CEPI): CEPI is a global partnership focused on accelerating vaccine development against epidemic threats. While it operates at a much larger scale, CEPI's mission of pandemic preparedness and outbreak response aligns with GET's strategic positioning.
- Africa CDC: Africa CDC is the African Union's continental public health agency with a mandate for biosecurity, outbreak response, and laboratory network coordination across all 55 AU member states. It is the most direct continental counterpart to GET's biosecurity and pandemic preparedness mission, though it operates at significantly larger scale and budget.
- World Health Organization Regional Office for Africa (WHO AFRO): WHO AFRO is the WHO's regional office for Africa, coordinating health security, laboratory strengthening, and outbreak response across the continent. It is a key policy counterpart and potential partner or competitor for GET's regional health security mandate.
Emerging players
- Africa Research Excellence Fund (AREF): AREF is a pan-African organisation that develops the research leadership capacity of African health researchers through fellowships and training. It shares GET's interest in building African scientific talent in health and biosecurity.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Global Emerging Pathogens Treatment Consortium social profiles
Digital presenceGlobal Emerging Pathogens Treatment Consortium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Emerging Pathogens Treatment Consortium leadership team
Management profileNumber of profiles
Profiles10 records
Global Emerging Pathogens Treatment Consortium subsidiaries and ownership
Company hierarchySubsidiaries1 record
Global Emerging Pathogens Treatment Consortium funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Emerging Pathogens Treatment Consortium M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Emerging Pathogens Treatment Consortium
What does Global Emerging Pathogens Treatment Consortium do?
Global Emerging Pathogens Treatment Consortium (GET) is a Pan-African non-profit consortium that delivers research, policy advocacy, training, and operational biosecurity infrastructure for pandemic preparedness across Africa. It operates the Lagos State Public Health Molecular Laboratory and Biobank Facility, runs the annual African Conference on One Health and Biosecurity, manages educational programs (Biosecurity Fellowship, One Health School Club), and conducts working groups spanning ethics, plasmapheresis, biobanking, and disease modeling.
Is Global Emerging Pathogens Treatment Consortium a public or private company?
Global Emerging Pathogens Treatment Consortium is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Global Emerging Pathogens Treatment Consortium founded?
Global Emerging Pathogens Treatment Consortium was founded in 2014. It employs 51 to 100 people.
Where is Global Emerging Pathogens Treatment Consortium based?
Global Emerging Pathogens Treatment Consortium is headquartered in Ibadan, Nigeria, in the Africa region.
How does Global Emerging Pathogens Treatment Consortium make money?
Two revenue lines are on record. Conference Fees and Sponsorships are the primary driver. The others are grant Funding.
Who are Global Emerging Pathogens Treatment Consortium's main competitors?
Direct peers on record are West African Health Organization (WAHO), Institut Pasteur de Dakar, FIND (Foundation for Innovative New Diagnostics), Africa One Health University Network (AFROHUN), African Society for Laboratory Medicine (ASLM) and Nigeria Centre for Disease Control (NCDC). Broad incumbents are Coalition for Epidemic Preparedness Innovations (CEPI), Africa CDC and World Health Organization Regional Office for Africa (WHO AFRO). Africa Research Excellence Fund (AREF) is listed as an emerging player.
Does Global Emerging Pathogens Treatment Consortium have an API?
No public API is recorded for Global Emerging Pathogens Treatment Consortium.
What industry is Global Emerging Pathogens Treatment Consortium in?
Global Emerging Pathogens Treatment Consortium's product category is Public Health and Biosecurity Research Services. Its primary akta.pro industry code is HLAJAIAE, Emerging Pathogen & Outbreak Response Testing Networks, with a secondary code of HLAJAOAJ, One Health & Zoonotic Disease Partnerships (Human–Animal–Environment). Its NAICS code is 6215 and its SIC code is 8071.